Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aluminium acetotartrate is an organic acid salt formed from acetic acid and tartaric acid with aluminum. It acts as a topical astringent and disinfectant. The compound is used in 0.5–2% solutions as a nasal douche for respiratory tract conditions, in 1–3% solutions as a substitute for aluminum acetate solution, in concentrated form as a lotion for frostbite and balanitis, and as snuff (with boric acid) for atrophic rhinitis. It is also applied topically in ointment or cream form to promote healing of wounds or treat skin conditions such as erythrodermic psoriasis. Its mechanism of action involves protein precipitation on the skin or mucous membranes, leading to reduced inflammation and antimicrobial effects[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aluminium acetotartrate.